Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

82.42
BATS BZX Real-Time Price
As of 2:36pm ET
 -0.63 / -0.76%
Today’s Change
63.56
Today|||52-Week Range
121.95
-7.04%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 120.00, with a high estimate of 136.00 and a low estimate of 83.00. The median estimate represents a +45.60% increase from the last price of 82.42.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.00
Sales
$61.3M
Reporting Date
Apr 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -101.19%
 
 
 
 
 
 
Growthannually 302.14%
 
 
 
 
 
 

Sales

Growthquarterly -0.78%
 
 
 
 
 
 
Growthannually 54.86%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account